Articles in Business

Zacks.com

First Horizon Earnings Beat on Lower Expenses - Analyst Blog

4/17/2014, 1:10 pm from Zacks.com in Investing, Business, Earnings, Stocks

Driven by prudent expense management, First Horizon National Corp. ( FHN ) reported first quarter 2014 earnings per share of 19 cents, outpacing the Zacks Consensus Estimate by 4 cents.… Read More

Zacks.com

Philip Morris Beats on Q1 Earnings, Lags Revs - Analyst Blog

4/17/2014, 1:00 pm from Zacks.com in Investing, Business, Earnings, Stocks

Philip Morris International Inc. 's ( PM ) adjusted first quarter 2014 earnings per share of $1.19 beat the Zacks Consensus Estimate of $1.17 by 1.7%. However, earnings lagged the prior year… Read More

Zacks.com

Nike Extends Partnership with USATF - Analyst Blog

4/17/2014, 12:51 pm from Zacks.com in Investing, Business, Stocks

Athletic apparel, footwear and accessories retailer, Nike Inc. ( NKE ) and the track and field National Governing Body, USA Track & Field (USATF), extended their long standing partnership,… Read More

Zacks.com

AmEx Q1 Earnings Top, Expense Checked - Analyst Blog

4/17/2014, 12:50 pm from Zacks.com in Investing, Business, Earnings, Stocks

American Express Co. ( AXP ), or AmEx, reported its first quarter 2014 operating earnings per share of $1.33. The result outpaced both the Zacks Consensus Estimate of $1.30, and the year ago… Read More

Zacks.com

Gap Outlines Expansion Plan - Analyst Blog

4/17/2014, 12:46 pm from Zacks.com in Investing, Business, Stocks

Taking forward its intention to penetrate deeper into the $1.4 trillion global apparel retail market, The Gap Inc . ( GPS ) outlined its growth strategies at the Investor Meet held yesterday.… Read More

Zacks.com

Dr. Reddy's Launches Generic Lunesta - Analyst Blog

4/17/2014, 12:44 pm from Zacks.com in Investing, Business, Stocks

Dr. Reddy's Laboratories Ltd. ( RDY ) announced the launch of its therapeutic equivalent generic version of Sunovion Pharmaceuticals Inc.'s Lunesta tablets (1 mg, 2 mg and 3 mg). Lunesta is a… Read More

Zacks.com

Legal Settlement for Astellas Pharma - Analyst Blog

4/17/2014, 12:41 pm from Zacks.com in Investing, Business, Stocks

Astellas Pharma Inc. ( ALPMY ) announced that it has reached an agreement with the U.S. Department of Justice to resolve civil claims regarding the marketing of Mycamine for injection. Astellas… Read More

Zacks.com

Schlumberger Beats on Earnings, Revs Miss Ests - Analyst Blog

4/17/2014, 12:40 pm from Zacks.com in Investing, Business, Earnings, Stocks

The world's largest oilfield services provider Schlumberger Ltd. ( SLB ) reported adjusted first quarter 2014 earnings of $1.21 per share (excluding special items), beating the Zacks Consensus… Read More

Zacks.com

3D Systems to Buy Robtec - Analyst Blog

4/17/2014, 12:37 pm from Zacks.com in Investing, Business, Stocks

After the announcement of its strategic partnership with Staples Inc. ( SPLS ), on Monday (Apr 14), 3D Systems Corporation ( DDD ) yesterday announced that it intends to acquire a Latin American… Read More

Zacks.com

AbbVie Candidate in Pivotal Study - Analyst Blog

4/17/2014, 12:32 pm from Zacks.com in Investing, Business, Stocks

Pipeline updates are highly awaited events in the pharma biotech sector as they play an important role in deciding whether or not to invest in a particular company. These updates provide… Read More